Article Archive - Page 45 of 61 - Business Chemistry

Sustainability in the chemical and pharmaceutical industry – results of a benchmark analysis

by | May 2010

Growing awareness of sustainability The awareness of sustainability as the main issue of companies’ performance has considerably grown over the last years. The reasons for this development are manifold. On the one hand, global megatrends such as climate change,...

Performance improvement in pharmaceutical R&D through new outsourcing models

by | May 2010

Abstract The stimulation of innovation in the pharmaceutical industry through outsourcing of research and development (R&D) activities within the drug discovery and development process is analyzed. The empirical data were collected through interviews with experts...

REACH implementation costs in the Belgian food industry: A semi-qualitative study

by | May 2010

Abstract In this paper we discuss how companies in the Belgian food industry are affected by the REACH legislation and whether their competitiveness is weakened as a result. The study has been carried out through an extensive literature study, an electronic survey,...

New biocide active substances: needs and challenges in the EU as viewed by industry

by | May 2010

Abstract Emerging regulatory initiatives in the EU are driving towards more environmentally safe chemicals, used as such or in a wide range of products and applications. The aim of the regulations is also to foster and support the emergence of new or safer...

Mergers & acquisitions (M&A) in the pharmaceutical industry: the wheel keeps on turning

by | May 2010

Apredictionwasmade here in January 2009, that the market for company mergers and acquisitions in the pharmaceutical industry would continue to reach a high level in 2009, even after the announced cases of large M&As (e.g. Novartis/ Alcon, Roche/Genentech,...

« Older Entries

Next Entries »